Gender, Age
Item
patient must be a man or woman aged 18 to 65 years of age, inclusive
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Diagnosis of psoriasis, clinical evidence, medical history
Item
the patient must have an established diagnosis of psoriasis (based upon clinical evidence, and documented medical history [19])
boolean
C0033860 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0033860 (UMLS CUI [2,1])
C3887511 (UMLS CUI [2,2])
C0205210 (UMLS CUI [2,3])
Able to read, able to write, English, Mandarin, Korean, target language
Item
the patient must be able to read and write in the target language (english, mandarin or korean; or other relevant target languages)
boolean
C0586740 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0584993 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
C0586740 (UMLS CUI [3,1])
C0682398 (UMLS CUI [3,2])
C0584993 (UMLS CUI [4,1])
C0682398 (UMLS CUI [4,2])
C0586740 (UMLS CUI [5,1])
C0022774 (UMLS CUI [5,2])
C0584993 (UMLS CUI [6,1])
C0022774 (UMLS CUI [6,2])
C0586740 (UMLS CUI [7,1])
C0023008 (UMLS CUI [7,2])
C1521840 (UMLS CUI [7,3])
C0584993 (UMLS CUI [8,1])
C0023008 (UMLS CUI [8,2])
C1521840 (UMLS CUI [8,3])
Informed consent form
Item
each patient must sign an informed consent form (icf) indicating that he or she understands the purpose of and procedures required for the study and are willing to participate in the study
boolean
C0021430 (UMLS CUI [1])
diagnosis of psoriatic arthritis
Item
an established diagnosis of psoriatic arthritis
boolean
C0003872 (UMLS CUI [1])
medical history, Systemic treatment, DMARD, Arthritis, Spondylitis
Item
ever have received systemic treatment with a disease modifying antirheumatic drug (dmard) for arthritis or spondylitis (inflammatory back pain)
boolean
C0262926 (UMLS CUI [1,1])
C1515119 (UMLS CUI [1,2])
C4055380 (UMLS CUI [1,3])
C0003864 (UMLS CUI [1,4])
C0262926 (UMLS CUI [2,1])
C1515119 (UMLS CUI [2,2])
C4055380 (UMLS CUI [2,3])
C0038012 (UMLS CUI [2,4])
Psoriasis, Medical history, Systemic therapy including Infliximab, Golimumab, Ustekinumab, Adalimumab and Etanercept
Item
ever have received systemic treatment with a biologic therapy for psoriasis (including infliximab, golimumab, ustekinumab, adalimumab or etanercept)
boolean
C0262926 (UMLS CUI [1,1])
C1515119 (UMLS CUI [1,2])
C0033860 (UMLS CUI [1,3])
C0666743 (UMLS CUI [2])
C2353893 (UMLS CUI [3])
C1122087 (UMLS CUI [4])
C1608841 (UMLS CUI [5])
C0717758 (UMLS CUI [6])
Healthcare facility, employment history, current employment
Item
a history of employment in or are currently employed in the healthcare industry
boolean
C1286384 (UMLS CUI [1,1])
C0018704 (UMLS CUI [1,2])
C0552390 (UMLS CUI [2,1])
C0018704 (UMLS CUI [2,2])
Translation and linguistic validation, Screening questionnaire
Item
participated in the translation and linguistic validation of the EARP questionnaire
boolean
C0040712 (UMLS CUI [1,1])
C1134635 (UMLS CUI [1,2])
C0681291 (UMLS CUI [2,1])
C1519941 (UMLS CUI [2,2])
C1134635 (UMLS CUI [2,3])